NodThera Revenue and Competitors
Estimated Revenue & Valuation
- NodThera's estimated annual revenue is currently $4.8M per year.
- NodThera's estimated revenue per employee is $155,000
Employee Data
- NodThera has 31 Employees.
- NodThera grew their employee count by -3% last year.
NodThera's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Financial and Business Officer | Reveal Email/Phone |
5 | VP Chemistry | Reveal Email/Phone |
6 | VP Scientific Operations | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Senior Director Translational Science | Reveal Email/Phone |
9 | Chief Development Officer | Reveal Email/Phone |
10 | Senior Director Portfolio & Project Management | Reveal Email/Phone |
NodThera Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is NodThera?
NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We're building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Lexington, MA; all united by our shared ambition, enthusiasm and creativity.
keywords:N/AN/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NodThera News
2022-03-30 - Rough biotech market won't stop 5AM Ventures' new $750M ...
... materials research company Halio, biotech NodThera, medical device company Semprus, and biopharmaceutical company Pear Therapeutics.
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.6M | 59 | 69% | $73M |
